Literature DB >> 5753556

Genetic control of drug levels in man: phenylbutazone.

E S Vesell, J G Page.   

Abstract

Phenylbutazone was administered to seven pairs of identical (monozygotic) twins and to seven pairs of fraternal (dizygotic) twins. Individual half-lives ranged from 1.2 to 7.3 days. Subjects with identical genotypes (monozygotic twins) exhibited very similar phenylbutazone half-lives; significantly greater differences in half-life occurred in dizygotic twins. The previously established large variations among individuals in phenylbutazone metabolism appear to be genetically, rather than environmentally, determined.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5753556     DOI: 10.1126/science.159.3822.1479

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

Review 1.  Pharmacogenomics: challenges and opportunities.

Authors:  Dan M Roden; Russ B Altman; Neal L Benowitz; David A Flockhart; Kathleen M Giacomini; Julie A Johnson; Ronald M Krauss; Howard L McLeod; Mark J Ratain; Mary V Relling; Huijun Z Ring; Alan R Shuldiner; Richard M Weinshilboum; Scott T Weiss
Journal:  Ann Intern Med       Date:  2006-11-21       Impact factor: 25.391

2.  Pharmacogenetics, pharmacogenomics and ecogenetics.

Authors:  Arno G Motulsky; Ming Qi
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

3.  Genomic medicine: a new frontier of medicine in the twenty first century.

Authors:  Dhavendra Kumar
Journal:  Genomic Med       Date:  2007-04-24

4.  Salivary gland reaction to phenylbutazone.

Authors:  S Mirsky
Journal:  Can Med Assoc J       Date:  1970-01-17       Impact factor: 8.262

Review 5.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

6.  Influence of allopurinol on drug metabolism in man.

Authors:  M D Rawlins; S E Smith
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

7.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02

8.  Coumarin-7-hydroxylase activity in microsomes from needle biopsies of normal and diseased human liver.

Authors:  F Kratz
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

Review 9.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.